Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
eversyn | for broader use of nucleotide sugars. than ever.
eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
March 2025 – November 2026 · 5 captures · latest observed messagingeversyn | Making high-value glycans mainstream
Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in
25 March 2025 · eversyn | Making high-value glycans mainstreamarchived page
16 September 2025 · eversyn | Making high-value glycans mainstreamarchived page
17 January 2026 · eversyn | Making high-value glycans mainstreamarchived page
12 June 2026 · eversyn | Making high-value glycans mainstreamarchived page
5 November 2026 · eversyn | Making high-value glycans mainstreamcurrent websiteHistorical capture not publicly available
September 2023 – August 2024 · 3 captureseversyn | bioactive sugars for nutrition & biopharma
eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce
26 September 2023 · eversyn | bioactive sugars for nutrition & biopharmaarchived page
25 March 2024 · eversyn | bioactive sugars for nutrition & biopharmaarchived page
12 August 2024 · eversyn | bioactive sugars for nutrition & biopharmaarchived page
Seen February 2023 · 1 captureeversyn | for broader use of nucleotide sugars. than ever.
eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce